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Summary
Mismatch repair proteins, DNA damage-recognition proteins and translesion DNA polymerases
discriminate between Pt-GG adducts containing cis-diammine ligands (formed by cisplatin (CP) and
carboplatin) and trans-RR-diaminocyclohexane ligands (formed by oxaliplatin (OX)) and this
discrimination is thought to be important in determining differences in the efficacy, toxicity and
mutagenicity of these platinum anticancer agents. We have postulated that these proteins recognize
differences in conformation and/or conformational dynamics of the DNA containing the adducts.
We have previously determined the NMR solution structure of OX-DNA, CP-DNA and undamaged
duplex DNA in the 5'-d(CCTCAGGCCTCC)-3' sequence context and have shown the existence of
several conformational differences in the vicinity of the Pt-GG adduct. In this study we have used
molecular dynamics simulations to explore differences in the conformational dynamics between OX-
DNA, CP-DNA and undamaged DNA in the same sequence context. Twenty-five 10 ns unrestrained
fully solvated molecular dynamics simulations were performed starting from two different DNA
conformations using AMBER v8.0. All twenty-five simulations reached equilibrium within 4 ns,
were independent of the starting structure and were in close agreement with previous crystal and
NMR structures. Our data show that the cis-diammine (CP) ligand preferentially forms hydrogen
bonds on the 5' side of the Pt-GG adduct, while the trans-RR-diaminocyclohexane (OX) ligand
preferentially forms hydrogen bonds on the 3' side of the adduct. In addition, our data show that these
differences in hydrogen bond formation are strongly correlated with differences in conformational
dynamics, specifically the fraction of time spent in different DNA conformations in the vicinity of
the adduct, for CP- and OX-DNA adducts. We postulate that differential recognition of CP- and OX-
GG adducts by mismatch repair proteins, DNA damage-recognition proteins and DNA polymerases
may be due, in part, to differences in the fraction of time that the adducts spend in a conformation
favorable for protein binding.
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Cisplatin (CP; cis-diamminedichloroplatinum(II)) and carboplatin (CBDCA,cis-
diammine-1,1-cyclobutanedicarboxylatoplatinum(II)) are widely used for treatment of
testicular cancer, ovarian cancer, head and neck tumors and a variety of other solid tumors.
However, many tumors are intrinsically resistant or develop acquired resistance to these
chemotherapeutic agents, and tumors that are resistant to one of these two platinum compounds
are usually cross-resistant to the other. The mutagenicity of CP in vivo1 is also of concern
because secondary malignancies have been associated with CP chemotherapy2. Considerable
effort has been made to develop third generation platinum anticancer agents that would not
share these limitations. Oxaliplatin (OX; trans-R,R-1,2-diaminocyclohexaneoxalatoplatinum
(II)) is one such compound, and has recently been approved for the treatment of colorectal
cancer and tumors that are resistant to CP and CBDCA. While OX does have some
mutagenicity3, it appears to be less mutagenic than CP4. CP and CBDCA form Pt-DNA
adducts that contain the cis-diammine carrier ligands, while OX forms Pt-DNA adducts that
contain the trans-RR-1,2-diaminocyclohexane carrier ligand. For simplicity, we will refer to
these as CP-DNA and OX-DNA adducts throughout this paper. Other than the differences in
carrier ligand, the adducts formed by CP, CBDCA and OX appear to be identical in terms of
the type of adduct formed (60-65% intrastrand GG, 25-30% intrastrand AG, 5-10% intrastrand
GNG and 1-3% interstrand) and the site of adduct formation5-7.
Because of their abundance, the intrastrand GG adducts are thought to be major determinants
of the cytotoxic response to platinum anticancer agents. The basis for the differences in tumor
range and mutagenicity of OX compared to CP and CBDCA is not known, but is thought to
be determined by the ability of proteins involved in damage recognition, damage repair and/
or damage tolerance to discriminate between CP and OX adducts. For example, hMSH2 and
MutS bind with greater affinity to CP-GG adducts than to OX-GG adducts8 ,9, and, as might
be expected from this difference in binding affinity, defects in mismatch repair result in
resistance to CP and CBDCA, but not to OX8 ,10-13. Similarly, a number of damage
recognition proteins and transcription factors, especially those with HMG domains, have been
shown to discriminate between CP- and OX-GG adducts14 ,15. The mechanism(s) by which
the binding of these proteins to Pt-DNA adducts influences the cytotoxic response is not known,
but has been postulated to involve shielding of the adducts from DNA repair and tolerance
mechanisms16-19, activation of signaling pathways leading to cell cycle arrest or apoptosis,
and/or hijacking of transcription factors needed for DNA replication or cell division15 ,20.
The binding specificity has been determined for only a few of these proteins, but where it has
been studied these proteins bind to CP-GG adducts with higher affinity than to OX-GG
adducts14 ,15 ,21. Finally, translesion DNA polymerases such as hpol β and hpol η have been
shown to bypass OX-GG adducts with higher efficiency than CP-GG adducts19 ,22 ,22 ,23,
which might contribute to the differences in CP and OX mutagenicity.
The CP- and OX-GG adducts form in the major groove and bend the DNA in the direction of
the major groove. The proteins that discriminate between CP- and OX-GG adducts either bind
to bent DNA or bend the DNA in the direction of the major groove after binding24-27. Because
these proteins primarily interact with the minor groove, we have hypothesized that the ability
of the proteins to discriminate between CP- and OX-GG adducts probably results from subtle
differences in conformation or conformational dynamics in the DNA containing the two
adducts rather than from physical interaction of the proteins with the carrier ligands of the
adducts in the major groove. A number of structures have been reported for CP-GG and OX-
GG adducts. The overall conformation of DNA containing these adducts appears to be similar,
but exact comparisons have been difficult to make because the structures have been determined
by different techniques (crystallography versus NMR), in different sequence contexts and with
oligonucleotides of different lengths. The NMR structures obtained to date have varied with
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respect to the number and resolution of NMR constraints obtained and the molecular mechanics
simulations used to convert the NMR constraints to final structures28-30. X-ray
crystallographic structures have been reported for the CP-GG and OX-GG adducts in the same
sequence context31, 32, but these structures may have been constrained by crystal packing
restraints. We have recently obtained high resolution NMR solution structures of the OX-
GG30, CP-GG adducts33 and undamaged DNA33 in the same mutagenic AGGC sequence
context (The underlined bases indicate the position of the Pt-GG adduct). The NMR studies
have identified several conformational differences between the solution structures of the two
Pt-GG adducts. In this study we have used molecular dynamics (MD) simulations to extend
this analysis to differences in conformational dynamics between CP-GG adducts, OX-GG
adducts and undamaged DNA in the AGGC sequence context. Our data are consistent with
earlier reports of greater distortion on the 5' side of Pt-GG adducts29 ,30 ,34-39. Our data are
also consistent with previous reports that the cis-diammine (CP) ligand preferentially forms
hydrogen bonds on the 5' side of the Pt-GG adduct, while the trans-RR-diaminocyclohexane
(OX) ligand preferentially forms hydrogen bonds on the 3' side of the adduct. Finally, our data
show that these differences in hydrogen bond formation are strongly correlated with differences
in conformational dynamics, specifically the fraction of time spent in different DNA
conformations, for CP- and OX-DNA adducts. These differences were particularly evident for
propeller twist, buckle, slide and shift in the vicinity of the Pt-GG adduct. We postulate that
these differences in conformational dynamics could allow differential recognition of CP- and
OX-GG adducts by critical DNA-binding proteins that influence the cytotoxic response to these
adducts. For example, we postulate that CP-GG adducts spend a greater percentage of time in
conformations favorable for binding of mismatch repair and HMG-domain DNA-binding
proteins, while OX adducts spend a greater percentage of time in conformations(s) favorable
for bypass by hpol β and hpol η. Experiments are currently underway to test these hypotheses.
Experiments are also underway to compare the effect of sequence context on the
conformational differences between these two adducts.
Results
The MD simulations were independent of starting structure
In total, twenty-five 10 ns unrestrained fully solvated molecular dynamics simulations were
performed starting from five different DNA conformations. In order to critically evaluate
whether the starting structures influenced the MD simulations, two very different starting
structures were used for both the CP-DNA and OX-DNA simulations. One of the starting
structures for the CP- and OX-DNA simulations used the NMR structure of DNA complexed
with hSRY (Protein DataBank accession code 1J46.pdb, bend angle = 54°) for the DNA
backbone. The other starting structures were based on the NMR structures of the CP-DNA
(Protein DataBank accession code 2NMW.pdb; bend angle = 22°) and OX-DNA (Protein
DataBank accession code 1PGC.pdb; bend angle = 31°) adducts alone. Idealized B-DNA was
used as the starting structure for the BDNA simulation. Five simulations each were performed
with the CP-SRY, CP-NMR, OX-SRY, OX-NMR and B-DNA starting structures as described
in methods. The all-atom mass-weighted root-mean-square deviations (RMSDs) referenced to
the corresponding NMR structures for the CP-DNA and OX-DNA structures and the starting
B-DNA structure for undamaged DNA calculated over all twenty-five trajectories were used
to determine how long it took the simulations to reach equilibrium and, in turn, the range of
trajectories to be used for the subsequent analyses. Plots of RMSD over time are shown for
CP-DNA (Figure 1A), OX-DNA (Figure 1B) and B-DNA (Figure S1). The average RMSD
plots of all ten CP-DNA simulations were within close proximity of one another within the
final 6 ns. Thus, the simulations of the CP-DNA adducts converged to similar equilibrium
structures even when the starting structures differed significantly in the initial degree of DNA
bending and/or MD initial velocity. Similar behavior was evident for the OX-DNA adducts.
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Based on these plots of average RMSD over time, we concluded that the simulations reached
equilibrium within 4 ns. Therefore our comparisons were made based on the final 6 ns of the
trajectories. The average RMSD compared to the NMR solution structures30 ,33 was 2.08 ±
0.43 Å over all ten simulations for OX-DNA, 2.73 ± 0.53 Å over all ten simulations for CP-
DNA and 2.80 ± 0.30 Å over all five simulations for B-DNA.
Comparison of the MD simulations with previously reported structures
For the purposes of comparison with previous structures, centroid structures (the structure from
the simulation with the lowest RMSD compared to the average structure) were determined for
both the CP-DNA and OX-DNA simulations. Figure 2 shows an overlay of the CP-DNA and
OX-DNA centroid structures and “sausage diagrams” of each structure individually showing
the overall variation in the structures during the simulations. The centroid structures of the CP-
DNA and OX-DNA adducts were very similar (The all atom RMSD for the DNA portion of
the structures was 1.3 Å). The “sausage diagrams” showed that the greatest variations in both
the CP-DNA and OX-DNA structures occurred at the ends of the DNA molecules, but that
there was relatively little fluctuation of the DNA backbone during the simulations.
The centroid structures of the CP-DNA and OX-DNA simulations were also compared with
the previous crystal31,32 and NMR30,33 structures of the same adducts (Figure 3). In both
cases, the simulations agreed slightly better with the NMR structures than the crystal structures.
For example, the all atom RMSD comparisons of the CP-DNA centroid structure with the
corresponding crystal31 and NMR33 structures were 4.2 Å and 3.1 Å, respectively. Similarly,
the all atom RMSD comparisons of the OX-DNA centroid structure with the corresponding
crystal32 and NMR30 structures were 4.0 Å and 3.1 Å, respectively. For the central four base
pairs, the RMSDs were 3.5 Å, 2.8 Å, 3.6 Å and 2.9 Å for the CP-crystal versus CP-centroid,
CP-NMR versus CP-centroid, OX-crystal versus OX-centroid and OX-NMR versus OX-
centroid, repectively.
In order to further assess how well the MD simulation structures agreed with our previously
reported NMR structures30,33, the extent to which the MD simulations reproduced NMR-
derived inter-proton distances was also evaluated. There were 171 and 160 inter-proton
distance constraints derived from NMR data within the central four base pairs 5'-d
(A5G6G7C8)-3' of CP-DNA and OX-DNA adducts respectively30 ,33. The statistics of the
inter-proton distance violations (defined as an inter-proton distance deviating from the range
of corresponding distance constraints by more than 0.5 Å, see Methods) are listed in Table 1
and the details of these distance violations are listed in Table S1 of Supplementary Data.
Overall, there were 2 (< 2%) and 5 (< 3%) violations for OX-DNA and CP-DNA respectively.
Most of the violations in CP-DNA simulation structures and one of the two violations in OX-
DNA simulation structures involved A5 and G6 nucleotides, which were on the 5' side of the
adduct and may represent the intrinsic dynamics of this portion of the molecule. Furthermore,
one of the OX-DNA violations and three of the CP-DNA violations involved sugar protons,
and may represent differences in sugar pucker, rather than differences in the position of the
purine or pyrimidine bases. The very small number of violations compared to the total number
of distance constraints indicated that our MD simulations largely reproduced the NMR data.
The geometry of the Pt-DNA adducts was also compared with previously reported structures
for the CP- and OX-DNA adducts (Table S2 in Supplementary Data). The platinum
displacement from the plane of the central guanines and the platinum out of guanine plane
bending angles were much closer to the previously reported values for the CP- and OX-DNA
adducts than was the recent MD simulation of a CP-DNA adduct reported by Elizondro-Riojas
and Kozelka40, possibly reflecting the refinement of partial charges that we derived and
utilized for these simulations. Our MD simulations do not reflect the differences between CP-
and OX-DNA adducts with respect to platinum displacement from the plane of the central
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guanines and the platinum out of guanine plane bending angles that were seen in our previous
NMR solution structures of the adducts30 ,33 (Table S2). However, it is important to note that
the position of the platinum is not directly determined by NMR constraints in the solution
structures and that the CNS software with the partial charges reported earlier by Yao et al41
and Scheef et al42 was used to derive the lowest energy solution structures. Thus, this
discrepancy between our MD simulations and the solution structures in the geometry of the
platinum adduct may simply reflect differences in structure refinement, such as partial charges
or differences between the AMBER and the CNS software used for calculations of the NMR
structures. AMBER and CNS use different force fields and the AMBER simulation was
performed under unrestrained and fully solvated condition, whereas CNS calculation used the
simulated annealing protocol in vacuum and was restrained by the inter-proton distance
constraints.
Principle Component Analysis of major conformational dynamics
Principle component analysis can be used to segregate large-scale correlated motions from
random thermal fluctuations, thereby probing the essential dynamics of the system. Principal
component analysis PCA is an orthogonal linear transformation that maps the data to a new
coordinate system so that the system can be deconvoluted along these coordinates. The order
of coordinates is rank-ordered according to their contribution to the motion of the system.
Principle component analysis was used to analyze the trajectories from each set of simulations
for major conformational motions. The first three principal components described >90% of the
essential modes of dynamics for the platinum-adducted DNA complexes. As expected for DNA
simulations, the first three components of conformational motions roughly corresponded to a
superposition of bending (Movie S1), twisting (Movie S2) and winding (Movie S3) motions,
in that order. By superimposing the major motions for CP- and OX-DNA adducts (Movies 1-3)
it is evident that the overall conformational flexibility of DNA containing CP-GG and OX-GG
adducts is very similar.
Hydrogen bonds
To assess the stability of the DNA duplex, the occupancy of all possible hydrogen bonds
(calculated as the percentage of the time during the simulation that the hydrogen bonds existed),
was measured for CP-DNA and OX-DNA adducts and B-DNA of the same sequence. The data
for Watson-Crick hydrogen bond occupancy are shown in Figure 4. When compared to B-
DNA, both CP-DNA and OX-DNA adducts show a significant decrease in standard Watson-
Crick hydrogen bond occupancy for the A5•T20 and G6•C19 base pairs on the 5' side of the
adduct, whereas the base pairs on the 3' side of the adduct are almost completely intact.
Two hydrogen bonds with significantly high occupancy between the platinum carrier ligand
and the DNA were identified and are shown in Figure 5. One is between the 3' amine hydrogen
of the platinum and the oxygen atom O6 of the 3' G7 and the other is between the 5' amine
hydrogen of the platinum and the nitrogen atom N7 of A5. For the CP-DNA adduct the amine
hydrogens are equivalent so only four combinations of hydrogen bond formation are possible.
The occupancy of each of these hydrogen bond combinations is summarized in Table 2A.
Differences in global DNA conformation associated with 5' only, 5' and 3' and 3' only hydrogen
bonds were minimal. However, significant conformational differences were observed in the
central four base pair region and these are shown in Figure S2. The CP-DNA adduct spends
40.2% of its time in conformations that allow formation of the 5' hydrogen bond only and
13.3% of its time in conformations that allow formation of the 3' hydrogen bond only. However,
the CP-DNA adduct also spends a significant amount of time (34.0%) in conformations that
allow formation of both the 5' and 3' hydrogen bonds. The total occupancy of the 5' and 3'
hydrogen bonds for the CP-DNA adduct is 74.2% and 47.2%, respectively. Thus, for the CP-
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DNA adduct the occupancy is greater for the hydrogen bond on the 5' side of the adduct,
suggesting that the CP-DNA adduct is preferentially oriented towards the 5' side.
For the OX-DNA adduct the situation is somewhat more complicated because the axial and
equatorial amine hydrogens are not equivalent (Figure 5). Thus, on the 5' side of the adduct,
the hydrogen bond between the axial hydrogen and N7 of A5 is not equivalent to the hydrogen
bond between the equatorial hydrogen and N7 of A5. However, on the 3' side of the adduct
only the equatorial hydrogen is in sufficient proximity to the O6 of G7 to form a hydrogen
bond. Thus, for the OX-DNA adducts there are six possible combinations of hydrogen bond
formation. The occupancy of each is summarized in Table 2B. As seen for the CP-DNA adduct,
differences in global DNA conformations associated with these hydrogen patterns were
minimal. The differences in DNA conformation in the central four base pair region associated
with 5' equatorial only, both 5' equatorial and 3' equatorial and 3' equatorial only hydrogen
bonds are shown in Figure S3. The OX-DNA adduct spends 34.2% of its time in conformations
that allow formation of the 3' hydrogen bond only and 13.7% of its time in conformations that
allow formation of 5' hydrogen bonds only. However, it also spends a significant amount of
time (40.9%) in conformations that allow simultaneous formation of both a hydrogen bond
between the equatorial hydrogen on the 5' side and N7 of A5 and a hydrogen bond between
the equatorial hydrogen on the 3' side and O6 of G7. The total occupancy of the 5' and 3'
hydrogen bonds for the OX-DNA adduct is 58.1% and 78.7%, respectively. Thus, for the OX-
DNA adduct the occupancy is greater for the hydrogen bond on the 3' side of the adduct,
suggesting that the OX-DNA adduct is preferentially oriented towards the 3' side.
DNA conformational dynamics
While the overall centroid structures of the CP-DNA and OX-DNA simulations were very
similar, we observed significant differences between the two simulations in terms of DNA
conformational dynamics. To determine the effect of CP- and OX-GG adducts on the
conformational dynamics of DNA, the frequency distributions (fraction of the time spent in
each conformation) from the trajectories of the CP-DNA, OX-DNA and undamaged DNA
simulations were calculated using the program CURVES v5.3. From previous comparisons of
CP- and OX-DNA adducts, it appeared that they were most likely to differ in terms of overall
bend angle and the DNA helical parameters of the central four base pair region30-33. The
overall bend angle was calculated from the CURVES output using MADBEND. No significant
differences in the frequency distribution of bend angles was observed for the CP- and OX-
DNA adduct simulations (data not shown). The frequency distributions of DNA helical
parameters for the central four base pairs were taken directly from the CURVES output and
were analyzed for statistical significance by the Kolmogorov-Smirnov test43 (Table S3). The
Kologorov-Smirnov test determines how significantly two distributions differ from each other,
without making any assumption regarding the distribution of data (non-parametric and
distribution-free). Cases in which the frequency distributions of DNA helical parameters were
significantly different from undamaged DNA for both CP- and OX-DNA adducts are indicated
in bold in Table S3. The distribution of frequency values for those helical parameters between
both types of Pt-DNA adducts and undamaged B-DNA are shown in Figure 6. When comparing
both Pt-DNA adducts to B-DNA, there were several striking differences identified, including
buckle and propeller twist for the A5·T20 base pair, shear and propeller twist for the G6·C19
base pair, buckle for the G7·C18 base pair; roll at the G6-G7 base pair step, and slide, tilt and
roll at the G7-C8 base pair step. These differences indicated that the conformational dynamics
profile of B-DNA was altered by the platinum adducts and are consistent with the previously
reported conformational distortions imposed on B-DNA by Pt-GG adducts28 ,29 ,31 ,32 ,44.
At the G6-G7 base pair step, the profiles of frequency distribution of roll were almost identical
for CP-DNA and OX-DNA adducts, which was consistent with the GG dihedral angles for
these two adducts.
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The significance of differences in the frequency distributions of DNA helical parameters
between CP- and OX-DNA adducts was also analyzed by the Kolmogorov-Smirnov test43
(Table S4). The distributions of those helical parameters showing the greatest difference
between CP- and OX-DNA adducts are shown in Figure 7, along with the distribution pattern
of undamaged B-DNA for comparison. When comparing CP-DNA adducts to OX-DNA
adducts, there were some noticeable differences. For base-base helical parameters, differences
were observed for propeller twist for the G6·C19 and G7·C18 base pairs and buckle for the
C8·G17 base pair. For base-pair-step helical parameters, differences were observed for slide
at the A5-G6, G6-G7 and G7-C8 base pair steps and shift at the G7-C8 base pair step. All of
the above differences suggest that CP-DNA and OX-DNA adducts differ in conformational
dynamics.
Correlation between platinum amine hydrogen bond formation and DNA conformational
dynamics
As described above the % occupancy for hydrogen bonds between the Pt-amine hydrogens and
nearby bases was greater on the 5′ side for the CP-DNA adduct and the 3′ side for the OX-
DNA adduct. The data described above indicated that the CP- and OX-DNA adducts primarily
influenced the conformational dynamics of the central four base pairs. Thus, to determine
whether the conformational dynamics of CP- and OX-DNA adducts might be influenced by
the formation of these hydrogen bonds, the trajectory data for DNA helical parameters for the
central 4 base pairs were separated according to the patterns of hydrogen bond formation
(Figures 8 and 9). The resulting frequency distributions were analyzed for significance by the
Kolmogorov-Smirnov test43 (Tables S5 and S6) and cases in which the frequency distribution
of DNA helical parameters associated with 5′ only hydrogen bonds were significantly different
than the DNA helical parameters associated with 3′ only hydrogen bonds are indicated in bold
Tables S5 and S6. The large number of examples in which the frequency distribution of DNA
helical parameters is associated with the pattern of hydrogen bond formation (5′ only versus
3′ only) suggests that the conformational dynamics of many of the DNA helical parameters in
the central four base pair region are strongly correlated with the pattern of hydrogen bond
formation.
Selected examples for the CP-DNA adduct are shown in Figure 8. For most of the DNA helical
parameters shown there is a clear difference in the distribution of DNA helical parameters
when the hydrogen bond exists on the 5′ side compared to when the hydrogen bond exists on
the 3′ side. In the case of the CP-DNA adduct, the two major hydrogen bond patterns are
hydrogen bond on 5′ side only (40.2%) and hydrogen bonds on both the 5′ and 3′ side (34.0%).
Furthermore, the frequency distributions of DNA helical parameters associated with these two
hydrogen bond patterns are generally either almost identical (A5-G6 slide) or very similar
(G6·C19 propeller twist, G7·C18 propeller twist, C8·G17 buckle, G6-G7 slide) G7-C8 shift,
G7-C8 slide). These data suggest that DNA conformations in which the hydrogen bonds are
seen on both the 5′ and 3′ side may represent conformational transitions between the 5′ only
and 3′ only hydrogen bond conformations.
For the OX-DNA adduct (Figure 9 and Table S6) there also appear to be clear differences in
the distribution of DNA helical parameters when the hydrogen bond exists on the 5′ side only
(either for the axial hydrogen or the equatorial hydrogen) compared to when the hydrogen bond
exists on the 3′ side only. In the case of the OX-DNA adduct, the two major hydrogen bond
patterns are a hydrogen bond with the equatorial hydrogen on 3′ side only (34.3%) and
hydrogen bonds with both the equatorial hydrogen on the 5′ and the equatorial hydrogen on
the 3′ side (40.9%). As with the CP-DNA adduct, the frequency distributions of DNA helical
parameters associated with these two hydrogen bond patterns are generally either almost
identical (G6-G7 twist, G7-C8 shift, G7-C8 slide) or very similar (G6·C19 propeller twist,
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G7·C18 propeller twist, C8·G17 buckle, G6-G7 slide). These data again suggest that DNA
conformations in which the hydrogen bonds are seen on both the 5′ and 3′ side may represent
conformational transitions between the 5′ only and 3′ only hydrogen bond conformations.
Finally, when one compares the data in Figures 8 and 9 with the data in Figure 7 it becomes
apparent that most of the conformational differences associated with hydrogen bond formation
in the CP- and OX-DNA adducts are highly correlated with the conformational differences
seen between CP- and OX-DNA adducts in Figure 7. For example, when one looks at propeller
twist at the G6·C19 base pair, the two major distribution patterns associated with 5′ hydrogen
bond formation (5′ only and both 5′ and 3′) of the CP-DNA adduct (representing 74.2% of the
total hydrogen bond occupancy) are centered at -18° to -16 ° (Figure 8), while the two major
distribution patterns associated with 3′ hydrogen bond formation (3′ only and equatorial 5′ plus
3′) for the OX-DNA adduct (representing 75.2% of the total hydrogen bond occupancy) are
centered at −29° and −21° (Figure 9). This precisely accounts for the difference in frequency
distribution patterns seen between CP- and OX-DNA adducts (−18° for CP and −25° for OX)
for G6•C19 propeller twist shift in Figure 7. Similar comparisons can be made for G7•C18
propeller twist, C8•G17 buckle, A5-G6 slide, G6-G7 slide, and G7-C8 slide.
However, these patterns are not universal. For G7-C8 shift, the differences in distribution
patterns between CP- and OX-DNA adducts in Figure 7 correlate with the major distribution
patterns for CP- and OX-DNA adducts in Figures 86 and 9, but the differences between 5' only
and 3' only hydrogen bond conformational distributions are not significant for either CP- or
OX-DNA adducts (Tables S5 and S6). At the opposite extreme, the 5' only and 3' only hydrogen
bond conformational distributions are significantly different for G6-G7 twist (Tables S56 and
S6)), but the major distribution patterns (5' only and both 5' and 3' for CP and 3' only and both
5' axial and 3' for OX) are very similar (22-26° for CP and 28° for OX). Thus, the distribution
patterns for CP- and OX-DNA adducts for G6-G7 twist are not significantly different (Table
S4).
Discussion
Accuracy of the MD simulations
Partial atomic charges for the platinum atom and the surrounding atoms of Pt-GG adducts are
not available in the standard AMBER force field and must, therefore be developed ab initio.
The previously available charges for CP-GG adducts were adopted by Yao et al41 from the
ab initio calculations of the [Pt(NH3)3(Ade)]2+ complex by Kozelka et al45 over 13 years ago.
The same atomic charge parameters were used by Scheef et al42 for simulations of the OX-
GG adduct, with the sole exception that the charge on the amine nitrogen was modified to
reflect its attachment to the cyclohexane ring. Although the partial charge parameters on the
CP-GG adduct have been updated by Elizondo-Riojas and Kozelka40, those charge parameters
were not actually reported. Because the partial charge parameters for the CP-GG adduct were
not derived empirically for a Pt-GG adduct and the OX-GG partial charge parameters had never
been determined empirically, we have developed new partial charge parameters for both CP-
GG and OX-GG adducts. The new partial charges on the platinum atom were similar to the
previous published values40 ,41. However, the new partial charges on the surrounding nitrogen
atoms were significantly different. Therefore, it was important to validate the accuracy of our
new partial charges in MD simulations.
Our MD simulations converged to a common set of structures within the first 4 ns that were
independent of the starting structure and MD initial velocities and these structures reproduced
the crystal and NMR solution structures of the same adducts in DNA by several criteria. First,
the simulation structures in the final 6 ns had an average RMSD of < 3 Å with respect to our
NMR solution structures (Figure 1). Second, the centroid structures had RMSDs of around 4.1
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Å compared to the corresponding crystal structures31,32 and around 3.1 Å compared to the
corresponding NMR structures30,33. Third, for the central 4 base pair region there were less
than 3% violations of NMR-derived inter-proton distance constraints for the CP-GG and OX-
GG adducts and the majority of these violations involved sugar pucker protons. Finally, both
CP-DNA and OX-DNA adducts in our MD simulations showed significantly increased roll
angle at the G6•G7 base pair step and the GG dihedral angle with respect to the undamaged
B-DNA, which is consistent with both the crystal and NMR solution structures of the Pt-DNA
adducts29-33. By all of these criteria, the MD simulations were excellent representations of
both the crystal and NMR solution structures of the same adducts. In addition, these MD
simulations provided a better estimation of the α angles and displacements of the platinum
atom out of the 5' and 3' guanine planes than the previous MD simulation of the CP-GG adduct
by Elizondo-Riojas and Kozelka40.
The DNA duplex is more distorted on the 5' side of the adduct than on the 3' side
We found a significantly greater decrease of occupancy of standard Watson-Crick hydrogen
bonds for the 5' A5•T20 and 5' G6·C19 base pairs than for the 3' G7·C18 base pair for both
CP-GG and OX-GG adducts, which suggests that the Pt-GG adduct is more distorted on the
5' side of the adduct than on the 3' side of the adduct. This is consistent with a number of
biological and structural studies that have indicated that Pt-GG adducts are more distorted on
the 5' side of the adduct than on the 3' side of the adduct. For example, several authors have
reported that the majority of misinsertion mutations occur opposite the 5'G of CP-GG
adducts34-36, and we and others have shown that hpol η has significantly greater difficulty
extending the DNA chain past the 5'G than the 3'G of either CP-GG or OX-GG
adducts37-39. With respect to structural studies, Marzilli et al29 have reported a faster
exchange rate between the water and imino protons of the 5'G of CP-GG adducts and we have
shown a faster exchange rate between water and imino protons of the 5'G of both the OX-
GG30 and CP-GG adducts33. Marzilli et al.29 also reported an unusually large positive shift
and slide at 5' X/G base pair step, and Elizondo-Riojas and Kozelka40, in their MD simulations,
have shown greater mobility of 5' G·C base pair with respect to the base pair 5' to the Pt-GG
adduct. All of these previous studies have indicated that the 5' G·C base pair was more flexible
and/or more distorted than the 3' G·C base pair.
Orientation of CP-DNA and OX-DNA adducts
In the crystal structure of CP-DNA adduct, a hydrogen bond was reported between the
hydrogen atom of the 5' oriented ammine NH3 ligand and an oxygen atom of the phosphate
group on the 5' side of the Pt-GG adduct31. In contrast, in the crystal structure of OX-DNA
adduct, a hydrogen bond was found between the 3' oriented amine NH2 group of the
diaminocycloheaxane ligand and the oxygen atom O6 of the 3'G32. Thus it has been suggested
that the cis-diammine carrier ligand of cisplatin was oriented more towards the 5' side of the
adduct and the (trans-R,R)1,2-diaminocyclohexane carrier ligand of oxaliplatin was oriented
more towards the 3' side of the adduct. However, neither hydrogen bond was observed in NMR
solution structures of the CP- and OX-GG adducts28,30,33. In this study, we assessed the
occupancy of these hydrogen bonds for both CP-DNA and OX-DNA adducts and found that
the occupancy of the hydrogen bond between the 5'-oriented NH3 and the phosphate oxygen
reported in the crystal structure of CP-DNA adduct was less than 1% for both CP-DNA and
OX-DNA adducts (Figure S4). In their work based on MD simulations of CP-DNA adduct,
Elizondo-Riojas and Kozelka40 have also reported that the formation of this hydrogen bond
is a very rare event, unless one considers the possibility of hydrogen bonds bridged by one or
two water molecules. The fact that this hydrogen bond is not observed at any significant level
in either NMR solution structures or MD simulations suggests that the formation of such a
hydrogen bond is a rare event and that the crystal structure of CP-DNA adduct happened to
capture this rare conformation, possibly due to crystal packing.
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However, we did observe significant occupancy of the hydrogen bond formed between the
hydrogen atom of the 5' ammine NH3 ligand of CP or the 5' amine NH2 group of
diaminocyclohexane ligand of OX and the nitrogen atom N7 of A5. The occupancy of this
hydrogen bond was higher for CP-DNA adduct (74.2%) than OX-DNA adduct (58.1%). We
also observed significant occupancy of the hydrogen bond formed between the hydrogen atom
of the 3' ammine NH3 ligand of CP or the 3' amine NH2 group of diaminocyclohexane ligand
of OX and the oxygen atom O6 of the 3' G7, which had been previously reported in the crystal
structure of the OX-DNA adduct, but not the CP-DNA adduct. The occupancy of this hydrogen
bond was higher for OX-DNA adduct (78.7%) than CP-DNA adduct (47.2%). The differences
in occupancy of hydrogen bonds between the ammine/amine hydrogen atoms of the CP/OX
and the bases on the 5' and 3' side of the Pt-GG adducts suggest a difference in the orientation
of Pt carrier ligands with respect to the DNA between CP- and OX-GG adducts. The cis-
diammine carrier ligand of CP appears to be oriented more towards the 5' side of the adduct
and the (trans-R,R)1,2-diaminocyclohexane carrier ligand of OX appears to be oriented more
towards the 3' side of the adduct. Thus our data are consistent with the observations reported
by Lippard and colleagues31 ,32 with respect to the preferential orientation of carrier ligands
of CP-DNA and OX-DNA adducts. This preferential formation of hydrogen bonds on the 5'
side of the CP-DNA adducts and on the 3' side of OX-DNA adducts is highly correlated with
differences in conformation and conformational dynamics of DNA containing CP- and OX-
GG adducts. We postulate that the hydrogen bond formation between the Pt-amine hydrogens
and adjacent bases drives some of the important conformational differences between CP- and
OX-DNA adducts.
These experiments do not address the possible effect of sequence context on the orientation of
CP- and OX-GG adducts. Our MD simulations were done in the AGGC sequence context,
while the crystal structures reported by Lippard and colleagues31 ,32 were in the TGGT
sequence context, which suggests that the relative orientation of CP- and OX-GG adducts are
similar in those sequence contexts. However, in the MD simulations of the CP-GG adduct in
the CGGA sequence context by Elizondo-Riojas and Kozelka40, a hydrogen bond was
observed on the 3' side of the adduct and between 3' NH3 ligand of the CP-GG adduct and N7
of the A on the 3' side of the adduct. This observation may help explain previous reports that
an A on the 3' side of Pt-GG adducts has a significant affect on the binding affinity and binding
specificity of DNA damage recognition proteins for CP-GG adducts. Experiments are currently
underway to determine the effect of sequence context on the orientation and conformational
dynamics of CP- and OX-GG adducts.
Differences in conformational dynamics between CP-DNA and OX-DNA adducts
From the comparison of frequency distribution of DNA duplex helical parameters, we observed
several differences which appear to reflect the distinct conformational dynamics between CP-
DNA and OX-DNA adducts. While the total range of DNA conformations explored by CP-
and OX-GG adducts is very similar, the fraction of time spent in these conformation by CP-
and OX-GG adducts differed with respect to several DNA helical parameters in the vicinity of
the Pt-GG adducts. We postulate that these differences in conformational dynamics could allow
differential recognition of CP- and OX-GG adducts by critical DNA-binding proteins that
influence the cytotoxic response to these adducts. While the differences in conformational
dynamics between CP- and OX-DNA adducts are relatively small, they are fully consistent
with the 1.5 to 2 fold differences in recognition of the adducts by most of the DNA-binding
proteins studied to date.
We postulate that CP-GG adducts spend a greater percentage of time in conformations
favorable for binding of mismatch repair and HMG-domain DNA-binding proteins, while OX
adducts spend a greater percentage of time in conformations(s) favorable for bypass by hpol
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β and hpol η. For example, the HMG domain of both HMG-A1 and HMG-B1 has been shown
to bind with higher efficiency to CP-GG adducts than to OX-GG adducts14 and the crystal
structure of the HMG-CP-DNA complex has been reported26. Since HMG binds to the CP-
DNA adduct on the 3'side of the adduct only26, the DNA helical parameters on the 3' side of
the HMG-CP-DNA complex are shown as vertical dashed lines in Figure 7 for comparison
with the frequency distributions of helical parameters for the CP-GG and OX-GG adducts. For
propeller twist of the G7•C18 base pair, buckle of the C8•G17 base pair and shift and slide at
the G7-C8 base pair step, the CP-GG adduct appears to spend a greater percentage of its time
in a conformation that is similar to the conformation of the HMG-CP-GG complex than the
OX-GG adduct. If any of these conformations are characteristic of the conformation of the
protein-DNA complex in the initial recognition step, they might facilitate the recognition of
the CP-GG adduct by the HMG domain. The conformational dynamics differences at the G7-
C8 base pair step might be particularly critical because both the affinity of the HMG domain
for the CP-GG adduct14 ,46 ,47 and the ability of the HMG domain to discriminate between
CP-GG and OX-GG adducts14 is highly dependent on the base to the 3' side of the adduct.
There are a number of important limitations inherent in such comparisons. We are comparing
a crystal structure of the HMG-CP-GG DNA complex with unrestrained simulations of the
CP-GG and OX-GG DNA adducts; the final, stable protein DNA complex likely has a different
conformation from the initial protein-DNA recognition complex; and the sequence context of
the CP-GG adduct in the HMG-CP-GG complex was different from the one in the CP-GG and
OX-GG simulations. To better characterize those conformational differences that are important
for differential protein recognition, experiments are underway to simulate the CP-GG and OX-
GG adducts in the same AGGC sequence context in complex with the HMG domains of one
or more proteins that discriminate between the adducts.
Methods
Starting structures
All five starting structures contained 12-mer DNA duplex in the same sequence context of 5'-
d(CCTCAGGCCTCC)-3' for the strand containing the platinum adduct. For the DNA portion
of the structures, the NMR solution structures of the OX-DNA adduct30 (Protein DataBank
accession code 1PGC.pdb) and the CP-DNA adduct33 (Protein DataBank accession code
2NPW.pdb) solved in our lab were used as two of the starting structures. For the CP- and OX-
DNA adducts, the DNA portion of the NMR solution structure of DNA complexed with hSRY
(Protein DataBank accession code 1J46.pdb) was also used as a starting structure for the DNA
backbone. The original DNA sequence from 1J46.pdb was mutated to the same DNA sequence
used for our NMR solution structures. Since the DNA backbone of the hSRY-DNA complex
was more bent than the DNA in the NMR solution structures of the Pt-DNA adducts by
themselves, it provided a test of whether our MD simulations were capable of driving
significantly distinct starting structures to non-distinguishable structures when simulations
reached equilibrium. For the platinum adducts on the DNA backbone derived from the
hSRY•DNA complex, the oxaliplatin adduct was obtained from our NMR solution structure
of OX-GG30 (1PGC.pdb) and the cisplatin adduct was obtained from the NMR solution
structure of the CP-GG adduct reported by Marzilli et al29 (1KSB.pdb). The Pt-GG adducts
were superimposed on the DNA from the hSRY•DNA complex, with removal of the two Gs
of the adduct producing the starting structures of the CP- and OX-DNA adducts. For
undamaged DNA, ideal B-DNA was used as the starting structure. The molecular modeling
package InsightII (www.accelrys.com) was used to perform all manual structural preparation
and building, including the undamaged DNA and the DNA sequence change for the CP- and
OX-DNA adducts.
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The atomic partial charges for CP-GG and OX-GG adducts are not defined in the standard
AMBER force field library. However, they are required and crucial in MD simulations. In
order to determine the atomic partial charges of CP-GG and OX-GG adducts, the 9-methyl-
guanine derivatives cis-[Pt(NH3)2(9-Me-Guo)2]2+ (CP-meG2) and [Pt(trans-RR-1,2-
diaminocyclohexane)(9-Me-Guo)2]2+ (OX-meG2) were used to simplify the calculation. These
derivatives were manually built from our NMR solution structures using Insight II. The atomic
partial charges were determined using the Mulliken method implemented within Gaussian03
based on either the structure geometry optimized by Gaussian03 or the NMR structure modified
to the 9-methyl-guanine derivative. The density functional method B3LYP implemented within
Gaussian03 was utilized; the LanL2DZ basis set was used for the platinum atom and 6-31Gd
basis set was used for the rest of the atoms. The Mulliken method was found to be insensitive
to the geometry of the structure and the resulting atomic partial charges were consistent in both
geometry optimized and non-optimized structures.
The partial charge of the platinum atom was close to the previously published values, while
the partial charges of four nitrogen atoms surrounding the platinum atom were significantly
different from the previously published values. The partial charges of the rest of the atoms
were within the theoretical range and comparable with their counterparts in the standard
AMBER force field. The Mulliken charges based on the structure of the original 9-methyl-
guanine derivative modified from our NMR solution structure were used without further
geometry optimization as the new atomic partial charges for Pt-GG adducts (Table S7,
Supplemental Data) and incorporated into our force field parameters. The atomic partial
charges of chemically equivalent atoms (such as the pseudo-equatorial hydrogen atoms of the
ammine group and the corresponding atoms in the two guanine bases) were averaged and the
small charge discrepancy due to the structural difference between 9-methyl-guanine and
deoxyguanine was distributed to the sugar according to the standard charge transfer technique
used by Yao et al.41. Besides the atomic partial charges, other force field parameters of the
Pt-GG adducts were referenced from AMBER parm99 force field parameters or from previous
work by Yao et al.41 and Scheeff et al.42. The MD simulation protocol is described in
Supplementary Materials.
MD simulations and trajectory analysis
Altogether twenty-five 10 ns unrestrained and fully solvated MD simulations were carried out
by using SANDER module of AMBER v8.0. There were five replicas for each of the five
starting structures described above. The five replicas differed only in the MD initial velocity
assigned when the system was heated for the last time. The atomic coordinates of the structures
were saved every 1 ps. Both the 5' and 3' terminal base pairs were excluded from analysis
because in several simulations the terminal bases were not base-paired and in some extreme
cases they were stacked with each other. In contrast with previous MD simulations of Pt-DNA
adducts, we did not use artificial constraints to hold the terminal base pairs together. Therefore
only the central ten base pairs were considered in trajectory analysis. The PTRAJ module of
AMBER v8.0 was employed for trajectory analysis.
Principle component analysis
The ptraj program from the AMBER v8 simulation software was used to perform principle
component analysis (PCA). The final 6 ns of equilibrated MD simulations of each of the 20
trajectories of CP-DNA and OX-DNA were subject to PCA analysis. The first three principal
components described >90% of the essential modes of dynamics for the platinum-adducted
DNA complexes. The dynamics of the first three principle components were visualized using
the PyMOL molecular graphics tool (DeLano Scientific, http://www.pymol.org).
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A distance of less than 3.5 Å and an angle of greater than 120° between the potential hydrogen
bond donor and acceptor were used as the criteria for a hydrogen bond formation. The
occupancy of one hydrogen bond was defined as the percentage of frames in which the
hydrogen bond existed. The hydrogen bond occupancy of one base pair was defined as the
average occupancy of hydrogen bonds existing within this base pair. For example, the hydrogen
bond occupancy of normal G·C base pair was the average occupancy of the three standard
Watson-Crick hydrogen bonds. However, there were hydrogen bonds formed between non-
complementary bases in damaged DNA adducts because of the distortion and misalignment
of bases. When calculating the hydrogen bond occupancy of base pairs, the occupancy of such
non-complementary hydrogen bonds of at least 5% was necessary for consideration and the
occupancy was split evenly between two base pairs.
Inter-proton distance constraint comparison
A set of inter-proton distance constraints have been derived from NMR data and used to
compute the NMR solution structures for the OX-DNA and CP-DNA30 ,33 by CNS
(Crystallography & NMR System) program. In the CNS calculations, a distance violation is
defined as an inter-proton distance deviating from the range of corresponding distance
constraints by more than 0.5 Å. The same criterion was applied here when we tried to evaluate
how well our MD simulation structures agreed with the NMR data. In addition, we classified
these constraints into several categories based on the locations of two protons. The two protons
may be from the same nucleoside, from two nucleosides within the same strand (intrastrand)
or from two nucleosides on different strands (interstrand). For each proton, it may be a base
proton or a sugar pucker proton. The H1' proton was treated as a base proton because its position
is largely independent of sugar pucker. All the other protons of the sugar were considered as
sugar pucker protons because their positions were strongly influenced by the sugar pucker
conformation. Only the distance constrains of the central four base pairs 5'-d(A5G6G7C8)-3'
were considered in this study.
DNA helical parameter analysis of trajectories
Five independent simulations with randomized initial velocities were performed for each of
the following starting conformations: CP-SRY (the CP-GG adduct, 1KSB.pdp, superimposed
on the DNA structure of the hSRY-DNA complex, 1J46.pdb), OX-SRY (the OX-GG adduct,
1PGC.pdb, superimposed on the DNA structure of the hSRY-DNA complex, 1J46.pdb), CP-
NMR (the NMR structure of the CP-DNA 2NPW.pdb), OX-NMR (the NMR structure of the
OX-DNA adduct, 1PGC.pdb) and B-DNA (constructed with Insight II (www.acelrys.com)).
The ptraj tool from AMBER-849 was used to extract the equilibrated conformations between
4 ns and 10 ns of simulation time, recording snapshots at every 1 ps time-interval of the five
independent runs of AMBER simulation trajectories. Using ptraj. these trajectory snapshots
were saved in the Protein DataBank (PDB) format, resulting in a total of (10000 − 4000) × 5
snapshots, i.e. 30,000 snapshots for each of CP-SRY, OX-SRY, CP-NMR, OX-NMR and B-
DNA simulations.
Each nucleotide type was converted from AMBER format to PDB format, and the resulting
snapshots were subjected to CURVES analysis. The following CURVES parameters were
extracted: global inter base-pair parameters: shift, slide, rise, tilt, roll and twist; global base-
base parameters: shear, stretch, stagger, buckle, propeller and opening. Histograms were then
constructed for percent occupancy versus discrete units of each DNA helical parameter.
Initially, for both CP-DNA and OX-DNA adducts histograms were constructed for the
CURVES parameters obtained with each starting structure (NMR and SRY) individually to
determine whether the starting structure affected the distribution of CURVES parameters.
Except for slight differences observed for shift at the A5•G6 base pair step, the CURVES
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parameters were not influenced by starting structure (data not shown). For CP-DNA and OX-
DNA simulations, the CURVES trajectories for both the SRY and NMR starting structures
were combined to get better statistics of fluctuations in the CURVES parameters (60,000
snapshots each). Percentage occupancy distributions of the DNA helical parameters were
calculated by normalizing the frequency distributions to 100%.
The Kolmogorov-Smirnov test43 was performed for each helical parameter to calculate the
P value for differences between CP-DNA vs. OX-DNA adducts (Table S5) and between B-
DNA and both CP-DNA and OX-DNA adducts (Table S4). The Kologorov-Smirnov test
determines how significantly two distributions differ from each other, without making any
assumption regarding the distribution of data (non-parametric and distribution-free). For ease
of comparison P values were reported on a negative logarithmic scale, −log(P) such that larger
values imply greater statistical difference (Tables S4 & S5). In order to determine which of
these −log(P) values were significant, the Kolomogorov-Smirnov test was also performed for
the same helical parameters comparing 5 individual simulations of the same structure (i.e. 5
for CP-DNA, 5 for OX-DNA and 5 for B-DNA). The highest −log(P) value obtained from
comparisons of the same structure was considered to set the threshold of significance. Only
−log(P) values for the comparisons between CP-DNA and OX-DNA or between B-DNA and
both CP-DNA and OX-DNA that were greater than the −log(P) value for comparisons of the
same structures were considered significant.
Correlation of patterns of hydrogen bond formation with DNA helical parameters
A trajectory-wide binary profile of all combinations of the presence and absence of the
following hydrogen bonds was generated using the hydrogen bond occupancy procedure
described above: CP-DNA: 5' side: 5' Pt-amine hydrogen to 5N7; 3' side: 3' Pt-amine hydrogen
to 7O6 and OX-DNA: 5' side: 5' Pt-amine equatorial hydrogen to 5N7; 5' Pt-amine axial
hydrogen to 5N7; 3' side: 3' Pt-amine equatorial hydrogen to 7O6. DNA helical parameters of
the corresponding trajectory snapshots were recorded using the helical parameter analysis
procedure described above. Histograms were then constructed for percent occupancy versus
discrete units of each DNA helical parameter for each of these hydrogen-bond combinations.
The Kolmogorov-Smirnov test43 was performed for each helical parameter to calculate P
values for the differences between 5' hydrogen bond only and 3' hydrogen bond only for both
the CP-DNA (Table S6) and the OX-DNA adducts (Table S7). The significance of these P
values was determined as described above.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Average RMSDs for the MD simulations over time
The RMSDs for each of the 20 simulations compared to the corresponding NMR solution
structure30 ,33 for the CP-DNA (Figure 1A) and OX-DNA adducts (Figure 1B) are shown for
the full 10 ns of each simulation. RMSD at time t represents the average of RMSD from time
zero to time t. CP-NMR and OX-NMR represent simulations starting from NMR solution
structures of the Pt-DNA 12-mer duplexes. CP-SRY and OX-SRY stand for simulations
starting from the more distorted DNA•SRY structures. The five simulation trajectories starting
from CP-NMR and OX-NMR structures with different initial MD velocities are represented
as solid lines (circle symbol), dotted lines(square symbol), dashed lines (diamond symbol),
long dashed lines (upward triangle symbol) and dot-dashed lines (left triangle symbol). The
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five simulation trajectories starting from the more distorted CP-SRY and OX-SRY structures
with different initial MD velocities are represented as solid lines (downward triangle symbol),
dotted lines (right triangle symbol), dashed lines (plus symbol), long dashed lines (cross
symbol) and dot-dashed lines (asterisk symbol).
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Average CP-DNA and OX-DNA structures were obtained using the AMBER ptraj tool. In
each case, the overall average structure was computed over the equilibrated final 6 ns
trajectories combined for the five independent simulations starting with the CP-SRY, CP-NMR
and OX-SRY, OX-NMR respectively. Pairwise Kabsch alignment was performed for the SRY
and NMR starting structures. Because the RMSDs indicated that the starting structure had little
influence on the average structure (RMSD = 0.83 Å for CP-SRY versus CP-NMR and 1.03 Å
for OX-SRY versus OX-NMR), the two average structures were further averaged to obtain a
single average structure for the last 6 ns of all 10 simulations of the CP-DNA and OX-DNA
adducts. Kabsch alignment was then performed against CP-DNA and OX-DNA average
structures against every 1 ps snapshot of simulation trajectory. The CP-DNA and OX-DNA
MD simulation snapshots having lowest RMS deviations with corresponding average
structures were selected as the centroid structures. A. Overlay of CP-DNA and OX-DNA
centroid structures. Cyan = OX-DNA; purple = CP-DNA. B and C “Sausage diagrams” of CP-
DNA and OX-DNA centroid structures, respectively. Root mean square atomic fluctuations
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of the CP-DNA and OX-DNA phosphate backbone were obtained by averaging the backbone
fluctuations over the 30000 snapshots of equilibrated final 6 ns of all 10 simulation trajectories.
The atomicfluct routine in the AMBER ptraj tool was used to compute these fluctuations. The
backbone thickness and color (in a scale varying from blue to red) corresponds to the relative
fluctuations of CP-DNA (B) and OX-DNA (C) backbone phosphates.
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Figure 3. Comparison of CP-DNA and OX-DNA centroid structures with previously determined
crystal and NMR structures
Pairwise Kabsch alignment of the centroid structure (cyan) obtained from the CP-DNA and
OX-DNA simulations versus the corresponding crystal structures (red) and NMR structures
(orange). The NMR solution structures of CP-DNA33 and OX-DNA30 (Protein DataBank
entries 2NPW and 1PG9, respectively) in the d(CCTCAGGCCTCC)-3' sequence context were
used to compare against corresponding centroid structures. The crystal structures
corresponding to CP-DNA31 and OX-DNA32 were derived from the available structures in
the 5'-d(CCTCTGGTCTCC)-3' sequence context (Protein DataBank entries 1AIO and 1IHH,
respectively). Representative crystal structures in the 5'-d(CCTCAGGCCTCC)-3' sequence
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context were derived by mutating the nucleotide sequence using Tripos Sybyl. Pairwise Kabsch
alignment of the CP-DNA and OX-DNA centroid structures was performed using PyMol's
pair_fit tool.
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Figure 4. Hydrogen bond occupancy of the central four base pairs
The hydrogen bond occupancy of the central four base pairs was calculated as described in
Methods. The standard Watson-Crick hydrogen bond occupancy of base pairs for B-DNA
(circle), CP-DNA (square) and OX-DNA (triangle) are shown.
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Figure 5. Hydrogen bonds between platinum carrier ligands and DNA
Structures illustrating observed hydrogen bond formation between Pt-amine hydrogens and
the surrounding DNA bases are shown for both the CP-DNA adduct (left) and the OX-DNA
adduct (right). The DNA backbone is shown in light gray for the strand containing the Pt-DNA
adduct and darker gray for the complementary strand. The Pt adduct including the carrier ligand
is shown in maroon. For the CP adduct, all amine hydrogens are in equilibrium and are shown
in cyan. For the OX adduct the amine hydrogens are not in equilibrium. The equatorial
hydrogen is shown in cyan and the axial hydrogen is shown in light blue. The dashed lines
illustrate the potential hydrogen bonds between the platinum amine groups and the DNA bases.
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Figure 6. Frequency distributions of representative DNA duplex helical parameters for the central
four base pairs: Differences between Pt-DNA adducts and undamaged DNA
Frequency distributions of each DNA duplex helical parameter for the central four base pairs
were calculated from the simulation trajectories by CURVES v5.3 as described in Methods.
The frequency distribution histograms were calculated from the structures obtained at every
picosecond over the final 6 nanosecond of each equilibrated MD simulation. Thus, the
histograms for CP-DNA and OX-DNA adducts were derived from 60,000 structures, while the
histograms for undamaged DNA were derived from 30,000 structures. Selected frequency
distributions that show differences between Pt-DNA adducts and undamaged DNA are shown.
B-DNA (dotted lines with diamond symbols); CP-DNA (solid lines with circle symbols); OX-
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DNA (long dashed lines with square symbols) (The symbols do not represent the data ponts;
rather they are shown to help distinguish the curves).
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Figure 7. Frequency distributions of representative DNA duplex helical parameters for the central
four base pairs: Differences between CP-DNA and OX-DNA adducts
Frequency distributions of each DNA duplex helical parameter for the central four base pairs
were calculated from the simulation trajectories by CURVES v5.3 as described in Methods.
The frequency distribution histograms were calculated from the structures obtained at every
picosecond over the final 6 nanosecond of each equilibrated MD simulation. Thus, the
histograms for CP-DNA and OX-DNA adducts were derived from 60,000 structures, while the
histograms for undamaged DNA were derived from 30,000 structures. Selected frequency
distributions that show differences between CP-DNA and OX-DNA adducts are shown. B-
DNA (dotted lines with diamond symbols), CP-DNA (solid lines with circle symbols); OX-
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DNA (long dashed lines with square symbols) (The symbols do not represent the data points;
rather they are shown to help distinguish the curves.) The vertical dash-dot lines show the value
of the corresponding DNA helical parameter on the 3' side of the adduct in the crystal structure
of the HMG-CP-DNA adduct26.
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Figure 8. Effect of hydrogen bonding patterns on frequency distributions of selected DNA duplex
helical parameters for the central four base pairs of CP-DNA adducts
The effect of hydrogen bond patterns between the Pt-amine hydrogens and adjacent DNA bases
on the frequency distributions of each DNA duplex helical parameter for the central four base
pairs of the CP-DNA adduct were determined as described in Methods. The frequency
distribution histograms were obtained from all of the CP-DNA structures containing a
particular hydrogen bond pattern (Table 2). Thus, the histograms for 5' only, 5' plus 3' and 3'
only hydrogen bonds were obtained from 24120, 20400 and 7980 structures, respectively.
Selected frequency distributions that show difference in the distribution of DNA helical
parameters when the hydrogen bond exists on the 5' side compared to when the hydrogen bond
exists on the 3' side of the CP-DNA adduct are shown. 3' Hydrogen bond only (solid lines with
square symbols); 5' hydrogen bond only (dotted lines with diamond symbols); hydrogen bonds
on both 3' and 5' sides (long-dashed lines with upward triangle symbols) (The symbols do not
represent the data points; rather they are shown to help distinguish the curves.) The frequency
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distributions for no hydrogen bonds on either the 3' side or 5' side are not shown for ease of
viewing.
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Figure 9. Effect of hydrogen bonding patterns on frequency distributions of selected DNA duplex
helical parameters for the central four base pairs of OX-DNA adducts
The effect of hydrogen bond patterns between the Pt-amine hydrogens and on adjacent DNA
bases on the frequency distributions of each DNA duplex helical parameter for the central four
base pairs of the OX-DNA adduct were determined as described in Methods. The frequency
distribution histograms were obtained from all of the OX-DNA structures containing a
particular hydrogen bond pattern (Table 2). Thus, the histograms for 5' axial only, 5' equatorial
only, 5' axial plus 3' equatorial and 3′ equatorial only hydrogen bonds were obtained from 3600,
4620, 24540 and 20500 structures, respectively. Selected frequency distributions that show
difference in the distribution of DNA helical parameters when the hydrogen bond exists on the
5′ side compared to when the hydrogen bond exists on the 3′ side of the OX-DNA adduct are
shown. 3′ Equatorial hydrogen bond only (solid lines with square symbols); 5′ axial hydrogen
bond only (dot-dashed lines with circle symbols); 5′ equatorial hydrogen bond only (dotted
lines with diamond symbols); hydrogen bonds with both 3′ equatorial and 5′ equatorial
hydrogens (long-dashed lines with upward triangle symbols) (The symbols do not represent
the data points; rather they are shown to help distinguish the curves. The frequency distributions
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for no hydrogen bonds on either the 3′ side or 5′ side and hydrogen bond formation for both
the 3′ equatorial and 5′ axial hydrogens are not shown for ease of viewing.
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Table 2
Occupancy of Hydrogen Bonds Between Platinum Amine Hydrogens and Nearby Bases on the DNA
Pattern of H Bond Formation % Occupancy of H Bond
5' Side 3' Side
A: CP-DNA Adduct






Pt-amine-axial-H • A5 Pt-amine-equitorial-H • G7
+ − 7.7%
+ + 3.5%
Pt-amine-equitorial-H • A5 Pt-amine-equitorial-H • G7
+ − 6.0%
+ + 40.9%
No Pt-amine-H • A5 Pt-amine-equitorial-H • G7
− + 34.3%
− − 7.6%
The percentage occupancy of hydrogen bonds between Pt-amine hydrogens and near-by DNA bases (see Figure 5) was calculated as described in Methods.
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